Explore the top headlines of the month, including insights on the latest clinical trials, therapeutic updates, and more.
News|Articles|January 29, 2025
Interview Intersection: Expert Interviews From January 2025
Author(s)Emma Andrus, Editor
Dermatology Times is recapping our top expert interviews from the month of January.
Advertisement
Advertisement
Samir Mitragotri, PhD, discussed the use of ionic liquids in dermatological therapeutics, highlighting their potential to enhance drug delivery through the skin. CAGE Bio's innovation, CGB-500, demonstrated impressive results in a phase 2a trial for atopic dermatitis, showing a 98% improvement in patients compared to placebo.
Related to this article
Dermatology Times is looking back on the top stories in dermatology from the month of October.
Face taping promises smoother skin and fewer wrinkles without injectables, but evidence suggests any visible benefits are largely temporary.
A pediatric dermatologist explains how CALM count, size, age, and associated findings separate benign spots from neurofibromatosis type 1 and its mimics.
At a Dermatology Times Case-Based Roundtable, Vishal A. Patel, MD, led a discussion on treatment selection, tolerability, and individualized care for patients with advanced basal cell carcinoma.
Phase 3 OptIMMize-1 findings show sustained skin clearance, itch reduction, and quality-of-life improvements with risankizumab through 52 weeks.
October brought FDA approvals in urticaria and HSV, new regulatory filings, and phase 3 advances in HS, psoriasis, and rare diseases.
Gaurav Singh, MD, explores how gene expression profiling may improve melanoma risk stratification, surveillance, and individualized care.
Advertisement
Advertisement